Guardant health, inc. (GH)
CashFlow / TTM
Mar'20Dec'19Sep'19Jun'19Mar'19Dec'18Sep'18Jun'18Mar'18
OPERATING ACTIVITIES:
Net loss

-78,329

-67,851

-71,013

-81,431

-91,770

-84,263

0

0

0

Adjustments to reconcile net loss to net cash used in operating activities:
Depreciation and amortization

12,361

11,411

10,132

9,183

8,095

7,136

0

0

0

Amortization of right-of-use assets

0

-

-

-

0

-

-

-

-

Charge of in-process research and development costs with no alternative future use

0

-

-

-

0

-

-

-

-

Unrealized translation gains (loss) on obligation related to royalty

3

147

436

203

707

357

0

0

0

Re-valuation of contingent consideration

0

-

-

-

0

-

-

-

-

Non-cash stock-based compensation

20,110

16,954

14,445

10,791

8,756

6,851

0

0

0

Non-cash interest expense

-

-

-

-

-

13

0

0

0

Amortization of premium (discount) on marketable securities

1,177

2,310

2,406

1,838

887

412

0

0

0

Others

0

-

-

-

0

-

-

-

-

Changes in operating assets and liabilities:
Accounts receivable, net

19,176

7,389

20,142

24,893

11,918

22,903

0

0

0

Inventory

14,892

6,045

7,685

7,448

3,290

1,849

0

0

0

Prepaid expenses and other current assets

7,836

6,185

1,633

1,045

3,298

3,663

0

0

0

Other assets

1,858

2,852

1,591

1,835

1,539

451

0

0

0

Accounts payable

16,442

4,341

2,124

7,636

447

5,046

0

0

0

Accrued compensation

8,252

5,571

17,174

8,725

10,380

8,075

0

0

0

Accrued expenses

6,245

9,213

6,113

743

1,486

286

0

0

0

Operating lease liabilities

0

-

-

-

0

-

-

-

-

Deferred rent

-

-

-

-

-

-1,307

0

0

0

Deferred revenue

-5,177

-3,861

9,140

12,623

12,509

13,025

0

0

0

Other liabilities

0

-

-

-

0

-

-

-

-

Net cash used in operating activities

-56,113

-47,134

-43,330

-66,724

-69,929

-72,185

0

0

0

INVESTING ACTIVITIES:
Purchases of marketable securities

624,084

614,290

781,225

662,221

313,782

287,450

0

0

0

Maturity of marketable securities

365,381

325,333

267,064

208,160

186,500

154,625

0

0

0

Purchases of property and equipment

25,610

18,717

14,559

14,595

18,887

20,203

0

0

0

Purchase of intangible assets

0

-

-

-

0

-

-

-

-

Net cash provided by investing activities

-312,095

-317,570

-538,616

-478,421

-146,169

-153,028

0

0

0

FINANCING ACTIVITIES:
Payments made on royalty obligations

238

311

228

151

73

0

0

0

0

Payments made on capital lease obligations

145

128

102

106

417

443

0

0

0

Proceeds from issuance of common stock upon exercise of stock options

12,605

11,639

10,334

6,907

2,339

3,111

0

0

0

Proceeds from issuance of common stock upon the exercise of warrants

-

-

-

-

-

45

0

0

0

Proceeds from issuances of common stock under employee stock purchase plan

0

-

0

0

0

-

0

0

0

Payment of offering costs related to initial public offering and follow-on offering

634

723

4,976

4,544

4,475

4,386

0

0

0

Net cash provided by financing activities

366,482

367,304

614,591

608,516

294,182

293,161

0

0

0

Net effect of foreign exchange rate changes on cash and cash equivalents

0

-

0

0

0

-

0

0

0

Net increase in cash and cash equivalents

-1,550

2,684

32,809

63,461

78,015

67,948

0

0

0

Supplemental Disclosures of Cash Flow Information:
Operating lease liabilities arising from obtaining right-of-use assets

0

-

-

-

0

-

-

-

-

Cash paid for interest

-

-

-

-

-

1,251

0

0

0

Cash paid for income taxes

-

-

-

-

-

-

-

-

0

Supplemental Disclosures of Noncash Investing and Financing Activities:
Purchases of property and equipment included in accounts payable and accrued expenses

0

-

-

-

0

-

-

-

-

Increase in purchases of property and equipment included in accounts payable and accrued expenses

-

-

-

-

-

897

0

0

0